TOP HEADLINES

Editor's Corner

UCLA, Harvard and others identify possible TB biomarker

There's a new biomarker in the mix that could help diagnose patients at high risk for tuberculosis and lead to targeted treatments to combat it.

Roche's Ventana expands infrastructure in Arizona

Roche's Ventana Medical Systems is building a new distribution center in Arizona and plans to generate additional jobs in the process.

FDA signs off on highly specific Type 1 diabetes biomarker test

The FDA has signed off on a new, highly specific biomarker blood test designed by an Idaho company to quickly spot Type 1 diabetes.

Flagship Biosciences and Sarepta will automate muscular dystrophy biomarker detection

Tissue-based companion diagnostics company Flagship Biosciences said it will join with Sarepta Therapeutics to automate and quicken measurement of a key biomarker for muscular dystrophy.

Illumina, AstraZeneca, Janssen and Sanofi to pursue universal companion Dx test

Illumina has inked deals with three major Big Pharma companies with a goal of developing a universal gene-sequencing companion diagnostic test system focused on cancer.

MORE NEWS

From Our Sister Sites

FierceBiotech

Amgen has taken another big step in its head-to-head race with Sanofi and Regeneron, filing its application for the prospective cholesterol blockbuster evolocumab and backing it up with more positive data from the latest in a long string of major clinical studies.

FiercePharma Manufacturing

In an effort to contain the Ebola outbreak in Africa that has already killed more than 1,500 people, companies around the world, including GlaxoSmithKline, are fast-tracking treatments and vaccines to try to get ahead of the disease spread. And in an effort to do that, companies are manufacturing doses, even as they are testing drugs, so that they will have product ready to go ASAP.